vs
Side-by-side financial comparison of LifeMD, Inc. (LFMD) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.
LifeMD, Inc. is the larger business by last-quarter revenue ($60.2M vs $55.4M, roughly 1.1× PLAYSTUDIOS, Inc.). LifeMD, Inc. runs the higher net margin — -6.3% vs -24.7%, a 18.4% gap on every dollar of revenue. On growth, LifeMD, Inc. posted the faster year-over-year revenue change (13.0% vs -18.3%). PLAYSTUDIOS, Inc. produced more free cash flow last quarter ($3.6M vs $-944.4K). Over the past eight quarters, LifeMD, Inc.'s revenue compounded faster (24.8% CAGR vs -15.6%).
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
LFMD vs MYPS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $60.2M | $55.4M |
| Net Profit | $-3.8M | $-13.7M |
| Gross Margin | 87.7% | — |
| Operating Margin | -3.3% | -17.7% |
| Net Margin | -6.3% | -24.7% |
| Revenue YoY | 13.0% | -18.3% |
| Net Profit YoY | 18.3% | 38.9% |
| EPS (diluted) | — | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $55.4M | ||
| Q3 25 | $60.2M | $57.6M | ||
| Q2 25 | $62.7M | $59.3M | ||
| Q1 25 | $64.1M | $62.7M | ||
| Q4 24 | — | $67.8M | ||
| Q3 24 | $53.3M | $71.2M | ||
| Q2 24 | $50.7M | $72.6M | ||
| Q1 24 | $44.1M | $77.8M |
| Q4 25 | — | $-13.7M | ||
| Q3 25 | $-3.8M | $-9.1M | ||
| Q2 25 | $-1.6M | $-2.9M | ||
| Q1 25 | $-183.8K | $-2.9M | ||
| Q4 24 | — | $-22.4M | ||
| Q3 24 | $-4.7M | $-3.1M | ||
| Q2 24 | $-6.9M | $-2.6M | ||
| Q1 24 | $-6.8M | $-567.0K |
| Q4 25 | — | — | ||
| Q3 25 | 87.7% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 86.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 90.1% | — | ||
| Q1 24 | 89.6% | — |
| Q4 25 | — | -17.7% | ||
| Q3 25 | -3.3% | -13.6% | ||
| Q2 25 | -0.7% | -5.9% | ||
| Q1 25 | 1.5% | -4.4% | ||
| Q4 24 | — | -33.1% | ||
| Q3 24 | -7.5% | -6.7% | ||
| Q2 24 | -12.4% | -5.5% | ||
| Q1 24 | -14.0% | -2.2% |
| Q4 25 | — | -24.7% | ||
| Q3 25 | -6.3% | -15.8% | ||
| Q2 25 | -2.6% | -5.0% | ||
| Q1 25 | -0.3% | -4.6% | ||
| Q4 24 | — | -33.1% | ||
| Q3 24 | -8.7% | -4.3% | ||
| Q2 24 | -13.6% | -3.6% | ||
| Q1 24 | -15.3% | -0.7% |
| Q4 25 | — | $-0.12 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | $-0.05 | $-0.02 | ||
| Q1 25 | $-0.02 | $-0.02 | ||
| Q4 24 | — | $-0.18 | ||
| Q3 24 | $-0.13 | $-0.02 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $104.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3M | $227.9M |
| Total Assets | $66.0M | $290.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $104.9M | ||
| Q3 25 | — | $106.3M | ||
| Q2 25 | $36.2M | $112.9M | ||
| Q1 25 | $34.4M | $107.1M | ||
| Q4 24 | — | $109.2M | ||
| Q3 24 | $37.6M | $105.2M | ||
| Q2 24 | $35.7M | $106.3M | ||
| Q1 24 | $35.1M | $127.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $15.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $227.9M | ||
| Q3 25 | $1.3M | $238.9M | ||
| Q2 25 | $-1.8M | $245.3M | ||
| Q1 25 | $-2.3M | $244.1M | ||
| Q4 24 | — | $244.7M | ||
| Q3 24 | $-7.7M | $265.2M | ||
| Q2 24 | $-4.2M | $263.6M | ||
| Q1 24 | $-845.3K | $288.4M |
| Q4 25 | — | $290.6M | ||
| Q3 25 | $66.0M | $299.2M | ||
| Q2 25 | $73.6M | $316.2M | ||
| Q1 25 | $73.6M | $313.8M | ||
| Q4 24 | — | $323.0M | ||
| Q3 24 | $72.6M | $330.6M | ||
| Q2 24 | $63.8M | $333.4M | ||
| Q1 24 | $61.5M | $357.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-147.1K | $3.7M |
| Free Cash FlowOCF − Capex | $-944.4K | $3.6M |
| FCF MarginFCF / Revenue | -1.6% | 6.5% |
| Capex IntensityCapex / Revenue | 1.3% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | $25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.7M | ||
| Q3 25 | $-147.1K | $5.7M | ||
| Q2 25 | $8.6M | $13.6M | ||
| Q1 25 | $3.1M | $3.3M | ||
| Q4 24 | — | $11.6M | ||
| Q3 24 | $6.7M | $14.6M | ||
| Q2 24 | $4.5M | $14.5M | ||
| Q1 24 | $5.2M | $5.0M |
| Q4 25 | — | $3.6M | ||
| Q3 25 | $-944.4K | $5.4M | ||
| Q2 25 | $7.8M | $13.2M | ||
| Q1 25 | $2.9M | $3.2M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $6.3M | $13.9M | ||
| Q2 24 | $3.9M | $12.8M | ||
| Q1 24 | $5.0M | $3.6M |
| Q4 25 | — | 6.5% | ||
| Q3 25 | -1.6% | 9.3% | ||
| Q2 25 | 12.5% | 22.3% | ||
| Q1 25 | 4.6% | 5.1% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | 11.7% | 19.6% | ||
| Q2 24 | 7.7% | 17.6% | ||
| Q1 24 | 11.4% | 4.6% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 1.3% | 0.5% | ||
| Q2 25 | 1.3% | 0.7% | ||
| Q1 25 | 0.2% | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.8% | 0.9% | ||
| Q2 24 | 1.3% | 2.4% | ||
| Q1 24 | 0.4% | 1.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFMD
| Telehealth Subscription Revenue | $27.3M | 45% |
| Telehealth | $20.0M | 33% |
| Work Simpli Revenue | $12.9M | 21% |
| Product And Services | $2.5M | 4% |
MYPS
Segment breakdown not available.
